Drug Shortage Report for CYCLOMEN

Last updated on 2020-02-10 History
Report ID 76396
Drug Identification Number 02018160
Brand name CYCLOMEN
Common or Proper name Cyclomen
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) DANAZOL
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code G03XA
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-03-15
Actual start date
Estimated end date 2020-02-17
Actual end date 2020-02-07
Shortage status Resolved
Updated date 2020-02-10
Company comments Delay in manufacturing. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-03-16 English Compare
v7 2019-03-11 French Compare
v6 2019-03-11 English Compare
v5 2019-02-21 French Compare
v4 2019-02-21 English Compare
v3 2019-02-20 French Compare
v2 2019-02-20 English Compare
v1 2019-02-20 English Compare

Showing 21 to 28 of 28